KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Depreciation & Amortization (CF) (2016 - 2025)

Edwards Lifesciences has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $42.7 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $42.7 million for Q4 2025, changed 0.23% from a year ago — trailing twelve months through Dec 2025 was $156.6 million (up 0.9% YoY), and the annual figure for FY2025 was $156.6 million, up 0.9%.
  • Depreciation & Amortization (CF) for Q4 2025 was $42.7 million at Edwards Lifesciences, up from $39.2 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for EW hit a ceiling of $42.7 million in Q4 2025 and a floor of $32.4 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $35.9 million (2021), compared with a mean of $36.6 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 46.12% in 2021 and later decreased 6.5% in 2024.
  • Edwards Lifesciences' Depreciation & Amortization (CF) stood at $33.0 million in 2021, then grew by 7.27% to $35.4 million in 2022, then grew by 3.67% to $36.7 million in 2023, then grew by 16.08% to $42.6 million in 2024, then increased by 0.23% to $42.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $42.7 million (Q4 2025), $39.2 million (Q3 2025), and $38.1 million (Q2 2025) per Business Quant data.